Lenacapavir
Lenacapavir, sold under the brand name Sunlenca, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is taken by mouth or by subcutaneous injection. Lenacapavir is a... Wikipedia
- Pronunciation: -kap -veer]]
- Trade names: Sunlenca, others
- AHFS/Drugs.com: Monograph
- MedlinePlus: a623005
- data: US DailyMed: Lenacapavir
- Pregnancy, category: AU: B1
- Routes of, administration: By mouth, subcutaneous
- Legal status: AU: S4 (Prescription only), CA: ℞-only, US: ℞-only, EU: Rx-only
- CAS Number: 2189684-44-2
- ATC code: J05AX31 (WHO)
- DrugBank: DB15673
- ChemSpider: 81367881
- UNII: A9A0O6FB4H
- KEGG: D12161, D12162
- ChEMBL: CHEMBL4594438
- Synonyms: GS-CA2, GS-6207
- PDB ligand ID: QNG (PDBe, RCSB PDB)
- Data source: DuckDuckGo